PuSH - Publikationsserver des Helmholtz Zentrums München: Genetically programmed changes in transcription of the novel progranulin regulator.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Keller, M. ; Gebhardt, C. ; Huth, S.* ; Schleinitz, D.* ; Heyne, H.* ; Scholz, M.* ; Stumvoll, M. ; Böttcher, Y.* ; Tönjes, A.* ; Kovacs, P.*

Genetically programmed changes in transcription of the novel progranulin regulator.

J. Mol. Med. 98, 1139–1148 (2020)

Verlagsversion

Forschungsdaten

DOI

PMC

	Open Access Hybrid

Abstract
Metriken
Zusatzinfos

Progranulin is a glycoprotein marking chronic inflammation in obesity and type 2 diabetes. Previous studies suggestedPSRC1(proline and serine rich coiled-coil 1) to be a target of genetic variants associated with serum progranulin levels. We aimed to identify potentially functional variants and characterize their role in regulation ofPSRC1. Phylogenetic module complexity analysis (PMCA) prioritized four polymorphisms (rs12740374, rs629301, rs660240, rs7528419) altering transcription factor binding sites with an overall score for potential regulatory function ofS(all) > 7.0. The effects of these variants on transcriptional activity and binding of transcription factors were tested by luciferase reporter and electrophoretic mobility shift assays (EMSA). In parallel, blood DNA promoter methylation of two regions was tested in subjects with a very high (N = 100) or a very low (N = 100) serum progranulin. Luciferase assays revealed lower activities in vectors carrying the rs629301-A compared with the C allele. Moreover, EMSA indicated a different binding pattern for the two rs629301 alleles, with an additional prominent band for the A allele, which was finally confirmed with the supershift for the Yin Yang 1 transcription factor (YY1). Subjects with high progranulin levels manifested a significantly higher mean DNA methylation (P < 1 x 10(-7)) in one promoter region, which was in line with a significantly lowerPSRC1mRNA expression levels in blood (P = 1 x 10(-3)). Consistently, rs629301-A allele was associated with lowerPSRC1mRNA expression (P < 1 x 10(-7)). Our data suggest that the progranulin-associated variant rs629301 modifies the transcription ofPSRC1through alteration of YY1 binding capacity. DNA methylation studies further support the role ofPSRC1in regulation of progranulin serum levels. Key messages(proline and serine rich coiled-coil 1) SNPs are associated with serum progranulin levels. rs629301 regulates expression by affecting Yin Yang 1 transcription factor (YY1) binding. is also epigenetically regulated in subjects with high progranulin levels.

Impact Factor

Scopus SNIP

Scopus
Cited By

Altmetric

4.427

1.048